ESMO 2020: Melanoma highlights through an Australian lens


In this lively case-study based panel discussion, our multidisciplinary experts discuss the hot topics in melanoma from ESMO 2020 including the latest research in neoadjuvant therapy and brain metastases, and what they mean for clinical practice in Australia today.
This webinar was recorded as a partnership between the limbic and Melanoma Institute Australia. It is suitable for medical oncologists, surgical oncologists, radiation oncologists, surgeons and other healthcare professionals. .
HOST
Professor Georgina Long AO
Co-Medical Director, Melanoma Institute Australia
Chair, Melanoma Medical Oncology and Translational Research,
Melanoma Institute Australia and Royal North Shore Hospital,
The University of Sydney
PANELLISTS
Professor Grant McArthur
Executive Director, Victorian Comprehensive Cancer Centre | Consultant Medical Oncologist, Peter MacCallum Cancer Centre | Head, Molecular Oncology Laboratory and Cancer Therapeutics Program, Peter MacCallum Cancer Centre | Lorenzo Galli Chair of Melanoma and Skin Cancers, University of Melbourne
Professor Angela Hong
Radiation Oncologist, Melanoma Institute Australia.
Dr Thomas Pennington
Surgical Oncologist, Melanoma Institute Australia, Royal Prince Alfred Hospital and Northern Beaches Hospital
Dr Bringha Shivalingam
Director of Neurosurgery, The Chris O’Brien Lifehouse | Consultant Neurosurgeon, Royal Prince Alfred Hospital and The Mater Hospital
Associate, Melanoma Institute Australia
- UN PACKING A CV FOR DIVERSE PATHWAYS IN ONCOLOGY
- Posted By Medical Oncology Group of Australia Incorporated (MOGA)
- Posted Date: 2020-12-17
- Location:Gold Coast QLD 4217
- Educational programs that address the clinical, research and professional development challenges